Search

everythinglearnresearchcommunity

for

Search:↓

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Dupilumab may help regrow hair in people with severe alopecia.

IVL3001 is safe, effective, and better than oral finasteride for treating hair loss.

Dupilumab may cause hair loss in some patients with severe atopic dermatitis.

Low-dose flutamide improved hirsutism and satisfaction in women but had common side effects, causing some to stop treatment.

Dupilumab for atopic dermatitis can cause mild skin issues in some patients.

Dupilumab effectively treats severe skin issues in a rare genetic disorder.

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Dupilumab can cause unexpected scalp issues, so early symptom recognition is important to avoid hair loss.

RADA16-I can effectively deliver and release mangiferin, improving its solubility and bioavailability.

Both treatments for alopecia areata are equally effective and safe.

Polymeric micelle nanocarriers deliver adapalene more effectively to hair follicles than commercial products.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

A patient's grey hair regained color during treatment with adalimumab.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

Increasing Teneligliptin on his own caused a man's hair loss, which stopped when he ceased the medication.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

Minimally invasive glaucoma surgery can effectively manage glaucoma in GAPO syndrome when other treatments fail.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

Tildrakizumab significantly improved psoriasis symptoms and well-being over 52 weeks.

A biodegradable system can deliver finasteride consistently, reducing the need for daily pills.

Secukinumab and acitretin together may quickly and effectively treat severe generalized pustular psoriasis.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

Dupilumab may cause hair loss, so patients should be monitored.

Adalimumab significantly improved Hidradenitis Suppurativa and quality of life in two patients.

IMSG nanoparticles improve vaccine delivery and immune response through hair follicles.

2-DG reduces seizures by enhancing brain inhibition through specific receptor activation.